- United States
- /
- Software
- /
- NasdaqGS:DOCU
DocuSign (DOCU) Q1 2027 Margin Compression Challenges Bullish Earnings Growth Narratives
DocuSign (DOCU) has kicked off Q1 2027 with total revenue of US$830.2 million and basic EPS of US$0.40, setting the stage for investors to reassess how the business is converting its top line into earnings. The company has seen quarterly revenue move from US$763.7 million in Q1 2026 to US$830.2 million in Q1 2027, while basic EPS shifted from US$0.35 to US$0.40 over the same stretch, giving you a clear read on how sales and earnings are tracking into the new fiscal year as margins come under closer scrutiny.
See our full analysis for DocuSign.With the latest earnings out, the next step is to see how these numbers line up with the widely held narratives around DocuSign's growth potential, profitability, and risk profile.
See what the community is saying about DocuSign
Margin picture: 9.6% net profit on US$3.3b TTM sales
- Over the last twelve months, DocuSign generated US$3.3b of revenue and US$315.2 million of net income, which works out to a 9.6% net profit margin compared with 36.5% a year earlier.
- Consensus narrative expects margins to work higher over time, and the current 9.6% level creates a tension with that view:
- Analysts are modeling margin expansion to 12.1% in about three years, alongside revenue growth of 7.5% per year. The trailing margin, however, sits well below last year’s 36.5% figure.
- This mix of modest forecast revenue growth and lower current margin means any improvement investors are watching for is not yet visible in the trailing 12 month numbers.
Valuation gap: US$47.26 vs DCF fair value of US$127.75
- The current share price of US$47.26 sits well below the stated DCF fair value of US$127.75, and the stock trades on a 29.1x P/E compared with 28.4x for the broader US software industry and 56.8x for the peer group.
- Bulls argue that DocuSign’s business can justify that DCF fair value, and the current metrics give them some support but also a few checks:
- Forecast earnings growth of about 15.4% per year and expectations for margins to move up from 9.6% are consistent with the idea of higher future earnings feeding into a higher valuation.
- At the same time, revenue growth of about 6.7% per year is below broader US market levels, so the share price discount to DCF fair value is not matched by standout top line growth in the forecasts.
Forecast growth vs margin compression worries
- Earnings are forecast to grow about 15.4% per year with revenue at about 6.7% per year, while the trailing net profit margin sits at 9.6% compared with 36.5% in the prior year.
- Bears focus on whether this margin profile can support those growth forecasts, and the reported figures give them some talking points:
- Critics highlight that margins have moved down sharply from last year’s 36.5% level. This lines up with concerns about pricing pressure and higher costs weighing on profitability.
- With revenue growth forecasts below the broader US market, the company has less room for error if higher spending is needed to defend share in a competitive agreement management market.
Next Steps
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for DocuSign on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
Seeing both the optimism around growth and the concerns on margins, it makes sense to check the underlying data yourself and decide where you stand. To help balance those views and move quickly from headline numbers to the full picture, take a look at the 2 key rewards and 1 important warning sign
See What Else Is Out There
DocuSign’s sharp margin compression from 36.5% to 9.6%, paired with only mid single digit revenue forecasts, leaves limited room if costs or competition rise further.
If that mix of squeezed profitability and modest growth makes you cautious, it might be time to focus on companies already priced attractively with stronger fundamentals through the 49 high quality undervalued stocks
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NasdaqGS:DOCU
DocuSign
Provides electronic signature solution in the United States and internationally.
Excellent balance sheet and good value.
Similar Companies
Market Insights
Weekly Picks

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets
Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Investment Analysis (May 2026)
Recently Updated Narratives

Making sense of 1.75 trillion IPO
SpaceX? Only Fast in - Fast out!

INDIAN OIL CORPORATION IS THE TITAN IN TRANSITION
Popular Narratives

Investment Analysis (May 2026)

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Honeywell - The Demand-Side of the AI Infrastructure
Trending Discussion
